Amid economic uncertainty, angel investors are reassessing their expectations of early-stage startups, and are backing ...

As employee fatigue deepens and Gen AI reshapes work, traditional HR tools are losing their persuasive power. Looking ahead ...

The post Employee Delivered A Major Fix That Saved The Company Money, But His Manager Stole The Credit Until The Company’s VP ...

Public records clearly shows that for the past 25 years, CERN has repeatedly built inadequate FPGA-based Level-1 Triggers, necessitating multiple rebuilds. During the Higgs boson discovery ...

Q2 2026 Earnings Call Transcript December 11, 2025 Operator: Good day, and welcome to the Culp, Inc. Second Quarter Fiscal ...

Karthik Ramgopal and Daniel Hewlett discuss the evolution of AI at LinkedIn, from simple prompt chains to a sophisticated ...

I hope this message allows all of you to heal and move on. The geopolitical environment is very confusing. But where some see ...

At Novocure, our mission is to extend survival for patients diagnosed with some of the most aggressive forms of cancer through the development of Tumor Treating Fields therapy. This quarter, we grew ...

Square Enix has had a rough couple of years—combining $140 million in losses from abandoned projects, the shine slowly fading from Final Fantasy 14 (even if it does look like things are on the up, ...

Quarterly Net Revenues Increase 12.3% , Driven by Growth in Motorhome and Towable RV Segments -- -- Improved Top-Line Performance and Cost ...

You've likely sat through dozens of terrible presentations and resented every minute. You know what I'm talking about: the identically themed slides, the walls of text, the monotone of the presenter's ...

Kyverna Therapeutics stock upgraded to Strong Buy after positive phase 2 results for miv-cel in SPS and MG. Read the latest analysis on the stock here.